ClassID:

94448

C07D235/16 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2 Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Recent Application in this class:
#1
20260008755
2026-01-08

INHIBITORS OF PROTEIN ARGININE DEIMINASE 1 AND METHODS OF PREPARATION AND USE THEREOF

#2
20250295636
2025-09-25

METHOD FOR PREPARING 4-[5-[BIS(2-CHLOROETHYL)AMINO]-1-METHYL-1H-BENZO[D]IMIDAZOL-2-YL]BUTYRIC ACID ALKYL ESTERS AND FORMYLATED DERIVATIVES

#3
20250276961
2025-09-04

COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS

#4
20250243184
2025-07-31

COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS

#5
20250114380
2025-04-10

SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME

#6
20250074882
2025-03-06

IMPROVED PROCESS FOR THE PREPARATION OF 5-[(4-BROMO-2-FLUOROPHENYL)AMINO]-4-FLUORO-N-(2HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE

#7
20240316059
2024-09-26

PEPTIDE DRUG CONJUGATES

#8
20240132479
2024-04-25

THERAPEUTIC COMPOUNDS AND USES THEREOF

#9
20240132467
2024-04-25

BENZIMIDAZOLE DERIVATIVES FOR TREATING RESPIRATORY DISEASE

#10
20240109842
2024-04-04

ACRYLAMIDE COMPOUNDS

#11
20240101536
2024-03-28

Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity

#12
20240043423
2024-02-08

COMPOUNDS AND METHODS FOR TREATMENT OF HEDGEHOG PATHWAY ASSOCIATED CONDITIONS

#13
20230391747
2023-12-07

GLP-1R MODULATING COMPOUNDS

#14
20230242496
2023-08-03

SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA

#15
20230234917
2023-07-27

ASPARAGINE DERIVATIVES AND METHODS OF USING SAME

#16
20230227412
2023-07-20

Substituted Benzimidazole Derivative And Use Thereof

#17
20230150927
2023-05-18

Cannabigerol derivatives and use thereof as cannabinoid receptor modulators

#18
20230134776
2023-05-04

Cannabinoid derivatives

#19
20230130361
2023-04-27

Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof

#20
20230128765
2023-04-27

Small Molecule Activators of Parkin Enzyme Function

#21
20230066771
2023-03-02

NUCLEAR RECEPTOR MODULATORS

#22
20230002328
2023-01-05

INHIBITORS OF PROTEIN ARGININE DEIMINASE 1 AND METHODS OF PREPARATION AND USE THEREOF

#23
20220411380
2022-12-29

ACID ADDITION SALT OF RORy REGULATOR

#24
20220340548
2022-10-27

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES

#25
20220233475
2022-07-28

NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE

#26
20220185963
2022-06-16

Crystalline, two dimensional polymers and a process for the preparation thereof

#27
20220135574
2022-05-05

BIARYL DERIVATIVE AS GPR120 AGONIST

#28
20220089550
2022-03-24

CRYSTALLINE FORMS OF (S)-2-(7-CYANO-1H-BENZIMIDAZOL-1 YL)-N-{1-[4-(1-CYANO-1-METHYLETHYL)PHENYL]ETHYL}ACETAMIDE

#29
20220017513
2022-01-20

Aromatic ring derivative as immunoregulation and preparation method and application of aromatic ring derivative

#30
20210347773
2021-11-11

Activator of TREK (TWIK RElated Kchannels) channels

#31
20210323930
2021-10-21

Voltage-dependent T-type calcium channel inhibitor

#32
20210214353
2021-07-15

Compounds and methods for treatment of hedgehog pathway associated conditions

#33
20210171499
2021-06-10

GLP-1R modulating compounds

#34
20210171471
2021-06-10

Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof

#35
20210171455
2021-06-10

Alpha-5 beta-1 inhibitors

#36
20210130293
2021-05-06

NUCLEAR RECEPTOR MODULATORS

#37
20210053952
2021-02-25

Fused imidazole derivatives as IL-17 modulators

#38
20200390728
2020-12-17

D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease

#39
20200323824
2020-10-15

NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE

#40
20200231547
2020-07-23

2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases

#41
20200155509
2020-05-21

Chemical compounds as antibiotics

#42
20200087283
2020-03-19

Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias

#43
20200046741
2020-02-13

SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME

#44
20190352282
2019-11-21

MCT4 inhibitors and uses thereof

#45
20190322662
2019-10-24

Activator of TREK (TWIK RElated K channels) channels

#46
20190194143
2019-06-27

GLUCAGON RECEPTOR ANTAGONISTS

#47
20190169158
2019-06-06

Small molecule activators of Parkin enzyme function

#48
20190077767
2019-03-14

Voltage-dependent t-type calcium channel blocker

#49
20190055196
2019-02-21

NUCLEAR RECEPTOR MODULATORS

#50
20190015390
2019-01-17

Solid forms of bendamustine hydrochloride

#51
20180354909
2018-12-13

SUBSTITUTED BENZIMIDAZOLIUM, PYRIDO-IMIDAZOLIUM, OR PYRAZINO-IMIDAZOLIUM COMPOUNDS AS CHEMOTHERAPEUTICS

#52
20180161313
2018-06-14

Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors

#53
20180147186
2018-05-31

BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME

#54
20180118711
2018-05-03

PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS

#55
20180105499
2018-04-19

Process for preparing alkyl esters of 4-(5-(bis(2-hydroxyethyl)amino-1-methyl-1H-benzo[D]imidazol-2-yl)butyric acid

#56
20180085383
2018-03-29

SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME

#57
20170349594
2017-12-07

Biaryl derivative as GPR120 agonist

#58
20170313663
2017-11-02

Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy

#59
20170246128
2017-08-31

Ddopamine receptor agonists to treat dyskinesia in Parkinson's disease

#60
20170182008
2017-06-29

Bendamustine derivatives and methods of using same

#61
20170166560
2017-06-15

Five-membered heterocycles useful as serine protease inhibitors

#62
20170143640
2017-05-25

Nanoparticulate and macroparticulate formulations

#63
20170071913
2017-03-16

Solid forms of bendamustine hydrochloride

#64
20170001964
2017-01-05

Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase

#65
20160362370
2016-12-15

Nuclear receptor modulators

#66
20160333009
2016-11-17

Benzimidazole and imadazopyridine carboximidamide compounds

#67
20160333004
2016-11-17

Substituted bicyclic heteroaryl compounds as RXR agonists

#68
20160289198
2016-10-06

Bendamustine derivatives and methods of using same

#69
20160200686
2016-07-14

Benzimidazolyl-methyl urea derivatives as ALX receptor agonists

#70
20160194289
2016-07-07

PROCESS FOR DRYING BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE

#71
20160159748
2016-06-09

Solid forms of bendamustine hydrochloride

#72
20160052890
2016-02-25

Compounds useful as antibiotic tolerance inhibitors

#73
20160031824
2016-02-04

Benzimidazole derivatives and uses thereof

#74
20160016912
2016-01-21

BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME

#75
20160002173
2016-01-07

Nanoparticulate and macroparticulate formulations

#76
20150291587
2015-10-15

Tricyclic compound

#77
20150274675
2015-10-01

Bendamustine derivatives and methods of using same

#78
20150259297
2015-09-17

Five-membered heterocycles useful as serine protease inhibitors

#79
20150232427
2015-08-20

Bendamustine derivatives and methods of using same

#80
20150196559
2015-07-16

Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives

#81
20150183747
2015-07-02

Pharmaceutical compositions

#82
20150175554
2015-06-25

Highly pure bendamustine hydrochloride monohydrate

#83
20150158863
2015-06-11

Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

#84
20150152066
2015-06-04

Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy

#85
20150105561
2015-04-16

Process for the preparation of bendamustine hydrochloride

#86
20150051258
2015-02-19

Novel Solid Forms Of Bendamustine Hydrochloride

#87
20150004533
2015-01-01

Actinic ray-sensitive or radiation-sensitive resin composition, and, actinic ray-sensitive or radiation-sensitive film and pattern forming method, each using the same

#88
20140378453
2014-12-25

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

#89
20140336194
2014-11-13

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

#90
20140323520
2014-10-30

Compositions and methods for increasing proliferation of adult salivary stem cells

#91
20140323518
2014-10-30

Estrogen receptor ligands

#92
20140315960
2014-10-23

Prodrugs of non-steroid anti-inflammatory agents (NSAIDS)

#93
20140309261
2014-10-16

2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)

#94
20140288302
2014-09-25

ACETIC ACID AMIDE DERIVATIVE HAVING INHIBITORY ACTIVITY ON ENDOTHELIAL LIPASE

#95
20140275567
2014-09-18

PROCESS FOR PREPARING ALKYL ESTERS OF 4-(5-(BIS(2-HYDROXYETHYL)AMINO)-1-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)BUTYRIC ACID

#96
20140275566
2014-09-18

Process for drying bendamustine hydrochloride monohydrate

#97
20140228380
2014-08-14

D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease

#98
20140228355
2014-08-14

Ddopamine receptor agonists to treat dyskinesia in parkinson's disease

#99
20140206706
2014-07-24

Five-membered heterocycles useful as serine protease inhibitors

#100
20140187598
2014-07-03

Solid forms of bendamustine hydrochloride

#101
20140179687
2014-06-26

Inhibitors of cyclophilins and uses thereof

#102
20140171363
2014-06-19

Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof

#103
20140155444
2014-06-05

Tetrahydronaphthalene derivatives

#104
20140121384
2014-05-01

Process for bendamustine hydrochloride

#105
20140121383
2014-05-01

Process for the preparation of bendamustine hydrochloride

#106
20140066419
2014-03-06

Hydroxamic acid derivatives

#107
20140038951
2014-02-06

PDE10 inhibitors and related compositions and methods

#108
20140031560
2014-01-30

Process for the preparation of bendamustine

#109
20140005175
2014-01-02

Substituted aromatic sulfur compounds and methods of their use

#110
20130317234
2013-11-28

Process for Preparation of Intermediates of Bendamustine

#111
20130310571
2013-11-21

METHODS FOR THE PREPARATION OF BENDAMUSTINE

#112
20130289032
2013-10-31

Esters of bendamustine and related compounds, and medical use thereof

#113
20130274243
2013-10-17

Chemical compounds

#114
20130267711
2013-10-10

TRICYCLIC COMPOUND

#115
20130245086
2013-09-19

Solid forms of bendamustine hydrochloride

#116
20130225594
2013-08-29

Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions

#117
20130217888
2013-08-22

PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE

#118
20130217685
2013-08-22

Compounds for modulating RNA binding proteins and uses therefor

#119
20130184471
2013-07-18

Process for the preparation of bendamustine hydrochloride and related compounds

#120
20130158273
2013-06-20

Preparation of bendamustine and its salts

#121
20130065896
2013-03-14

Fused imidazole derivative

#122
20130018044
2013-01-17

Inhibitors of cyclophilins and uses thereof

#123
20120283287
2012-11-08

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#124
20120276050
2012-11-01

Methods and compositions of treating a flaviviridae family viral infection

#125
20120142921
2012-06-07

Substituted hydrazide compounds and use thereof

#126
20120122944
2012-05-17

Tetrahydronaphthalene derivatives

#127
20120122844
2012-05-17

Method of treating contrast-induced nephropathy

#128
20120088758
2012-04-12

Five-membered heterocycles useful as serine protease inhibitors

#129
20120071532
2012-03-22

Solid forms of bendamustine hydrochloride

#130
20120053188
2012-03-01

Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives

#131
20120045616
2012-02-23

Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device

#132
20120028969
2012-02-02

Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof

#133
20110318807
2011-12-29

Small molecule inhibitors of ghrelin O-acyltransferase

#134
20110269806
2011-11-03

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors

#135
20110269736
2011-11-03

1,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use

#136
20110269706
2011-11-03

Hydroxamic acid derivatives

#137
20110251386
2011-10-13

Acetic acid amide derivative having inhibitory activity on endothelial lipase

#138
20110201640
2011-08-18

Tricyclic compound

#139
20110190509
2011-08-04

Processes for the preparation of bendamustine

#140
20110166102
2011-07-07

2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)

#141
20110086883
2011-04-14

Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

#142
20110065704
2011-03-17

Compounds for modulating RNA binding proteins and uses therefor

#143
20110021509
2011-01-27

PDE10 inhibitors and related compositions and methods

#144
20100298383
2010-11-25

NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)

#145
20100261909
2010-10-14

Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles

#146
20100240618
2010-09-23

Substituted piperazines

#147
20100228026
2010-09-09

Malonic acid sulfonamide derivative and pharmaceutical use thereof

#148
20100210701
2010-08-19

Forms of bendamustine free base

#149
20100204206
2010-08-12

Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them

#150
20100086955
2010-04-08

Small molecule inhibitors of ghrelin O-acyltransferase

#151
20100069453
2010-03-18

Certain Chemical Entities, Compositions, and Methods

#152
20100056545
2010-03-04

Phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of T-type calcium ion channel containing the same as an active ingredient

#153
20100048590
2010-02-25

N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS

#154
20100035872
2010-02-11

PDE10 inhibitors and related compositions and methods

#155
20090326012
2009-12-31

Malononitrile compounds

#156
20090312365
2009-12-17

Imidazopyridinyl benzamide mitotic kinesin inhibitors

#157
20090306127
2009-12-10

Imidazopyridinyl benzamide mitotic kinesin inhibitors

#158
20090286841
2009-11-19

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#159
20090275714
2009-11-05

Ruthenium complexes as catalysts for metathesis reactions

#160
20090264488
2009-10-22

NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE

#161
20090258909
2009-10-15

Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

#162
20090253656
2009-10-08

BCRP/ABCG2 inhibitor

#163
20090203912
2009-08-13

Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles

#164
20090184313
2009-07-23

Materials for organic electroluminescent devices

#165
20090181948
2009-07-16

DIAMINE DERIVATIVE

#166
20090181943
2009-07-16

Inhibitors of histone deacetylase

#167
20090105310
2009-04-23

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

#168
20090082416
2009-03-26

DEUTERIUM-ENRICHED BENDAMUSTINE

#169
20090054432
2009-02-26

2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors

#170
20090048300
2009-02-19

Heterocyclic compounds

#171
20090036438
2009-02-05

Five-membered heterocycles useful as serine protease inhibitors

#172
20090036422
2009-02-05

MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

#173
20080300240
2008-12-04

PDE10 inhibitors and related compositions and methods

#174
20080293684
2008-11-27

Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors

#175
20080287434
2008-11-20

New amino-alkyl-amide derivatives as CCR3 receptor ligands

#176
20080255182
2008-10-16

Certain chemical entities, compositions, and methods

#177
20080132539
2008-06-05

Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative

#178
20080132496
2008-06-05

CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS

#179
20080119534
2008-05-22

Benzimidazole Derivatives as Therapeutic Agents

#180
20080119522
2008-05-22

Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

#181
20080108678
2008-05-08

Cyclic derivatives as modulators of chemokine receptor activity

#182
20080015178
2008-01-17

BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND USE THEREOF AS MEDICAMENT

#183
20070267970
2007-11-22

NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME

#184
20070213330
2007-09-13

Inhibitors of histone deacetylase

#185
20070208014
2007-09-06

2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)

#186
20070155732
2007-07-05

Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents

#187
20070149516
2007-06-28

Imidazoyl-benzamide anti-cancer agents

#188
20060247289
2006-11-02

N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases

#189
20060205942
2006-09-14

2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

#190
20060194817
2006-08-31

N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds

#191
20060148805
2006-07-06

Opthalmic compositions for treating ocular hypertension

#192
20060142612
2006-06-29

Arylsulfonamide derivatives

#193
20060128765
2006-06-15

2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation

#194
20060116412
2006-06-01

Benzimidazole derivatives useful as selective androgen receptor modulators (sarms)

#195
20060111402
2006-05-25

Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

#196
20060106218
2006-05-18

Substituted piperazines

#197
20060079542
2006-04-13

Compounds and methods for treating insulin resistance and cardiomyopathy

#198
20060025464
2006-02-02

Benzimidazole derivatives as therapeutic agents

#199
20050282908
2005-12-22

Substituted aminopropoxyaryl derivatives useful as agonists for LXR

#200
20050282805
2005-12-22

Five-membered heterocycles useful as serine protease inhibitors

#201
20050272792
2005-12-08

Benzimidazoles, process for their preparation and use thereof as medicament

#202
20050260126
2005-11-24

Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein

#203
20050245518
2005-11-03

Inhibitors of histone deacetylase

#204
20050137168
2005-06-23

Heterocyclyl substituted 1-alkoxy acetic acid amides